Peritoneal Malignancy Treatment & Hyperthermic Intraoperative intraperitoneal chemotherapy (HIPEC) specialist Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a multimodal treatment for peritoneal mesothelioma and other abdominal cancers. The procedure combines surgery and a special approach to chemotherapy. It has significantly developed survival for peritoneal mesothelioma patients, but the part of heated chemotherapy in pleural mesothelioma treatment is less clear. Our Peritoneal Malignancy Treatment & Hyperthermic Intraoperative intraperitoneal chemotherapy (HIPEC) specialist in Pune location provides the best treatment to the patient and tries to make them healthy.
Apart from the growing number of studies reporting bigger survival after HIPEC, one of the procedure’s foremost draws is its less harsh side effects. With traditional chemotherapy, drugs enter the bloodstream and travel throughout the entire body. The drugs kill any cells that rapidly multiply — a key characteristic of cancer. A major downside of this approach is that it harms healthy cells that also multiply quickly, causing well-known chemotherapy side effects like hair loss and nausea.
Our Peritoneal Malignancy Treatment & Hyperthermic Intraoperative intraperitoneal chemotherapy (HIPEC) specialist in Pune, we treat the area where cancer formed. Because heated chemotherapy drugs stay inside the abdominal cavity, the approach reduces the rest of the body’s danger to chemotherapy. This allows doctors to give higher doses of drugs safely, with the added benefit of reduced side effects.
HIPEC doctors only select patients who will benefit from surgery. If the extent of tumor growth is too far advanced, or cancer has spread beyond the abdomen, HIPEC is no longer an effective treatment option.
There is always a chance that Our Peritoneal Malignancy Treatment & Hyperthermic Intraoperative intraperitoneal chemotherapy (HIPEC) specialist in Pune begins surgery only to find it is impossible to remove enough tumor growth to make HIPEC worthwhile. In cases like this, the procedure will not be effective. Clinical studies have shown that patients who receive complete or near complete removal of tumors before HIPEC have the best outcomes.
This process is done because the chemotherapy treatment have ability to lead more places in the abdomen while the abdomen is still accessible for surgery (it can be swished around and circulated inside the abdomen to reach more areas where cancer cells that are not visible to the naked eye may be hiding). In some cases, the chemo is circulated through tubes in the abdomen after the abdomen has been closed.
Patients at high risk for having cancer cells in the abdomen too small to be seen that remain after the larger tumors are removed (microscopic residual disease) are those with: